Albireo Pharma Stock Filter Stocks by Fundamentals
ALBODelisted Stock | USD 44.15 0.75 1.67% |
Albireo Pharma fundamentals help investors to digest information that contributes to Albireo Pharma's financial success or failures. It also enables traders to predict the movement of Albireo Stock. The fundamental analysis module provides a way to measure Albireo Pharma's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Albireo Pharma stock.
Albireo |
Did you try this?
Run Sign In To Macroaxis Now
Sign In To MacroaxisSign in to explore Macroaxis' wealth optimization platform and fintech modules |
All Next | Launch Module |
Albireo Fundamentals
Return On Equity | -0.93 | |||
Return On Asset | -0.25 | |||
Profit Margin | (2.29) % | |||
Operating Margin | (2.15) % | |||
Current Valuation | 259.98 M | |||
Shares Outstanding | 20.74 M | |||
Shares Owned By Insiders | 3.60 % | |||
Shares Owned By Institutions | 96.40 % | |||
Number Of Shares Shorted | 553.91 K | |||
Price To Earning | (4.16) X | |||
Price To Book | 4.30 X | |||
Price To Sales | 7.35 X | |||
Revenue | 40.58 M | |||
Gross Profit | 39.22 M | |||
EBITDA | (19.82 M) | |||
Net Income | (34.03 M) | |||
Cash And Equivalents | 180.97 M | |||
Cash Per Share | 9.23 X | |||
Total Debt | 10 M | |||
Debt To Equity | 0.18 % | |||
Current Ratio | 4.49 X | |||
Book Value Per Share | 4.84 X | |||
Cash Flow From Operations | (107.56 M) | |||
Short Ratio | 0.86 X | |||
Earnings Per Share | (6.66) X | |||
Target Price | 44.0 | |||
Number Of Employees | 130 | |||
Beta | 1.04 | |||
Market Capitalization | 915.89 M | |||
Total Asset | 302.05 M | |||
Retained Earnings | (171.75 M) | |||
Working Capital | 26.76 M | |||
Current Asset | 28.84 M | |||
Current Liabilities | 2.07 M | |||
Z Score | 54.6 | |||
Net Asset | 302.05 M |
About Albireo Pharma Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Albireo Pharma's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Albireo Pharma using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Albireo Pharma based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.Albireo Pharma, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of novel bile acid modulators to treat orphan pediatric liver diseases and other liver or gastrointestinal diseases and disorders. Albireo Pharma, Inc. is headquartered in Boston, Massachusetts. Albireo Pharma operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 130 people.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Albireo Pharma in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Albireo Pharma's short interest history, or implied volatility extrapolated from Albireo Pharma options trading.
Pair Trading with Albireo Pharma
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Albireo Pharma position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Albireo Pharma will appreciate offsetting losses from the drop in the long position's value.Moving together with Albireo Stock
0.83 | WMT | Walmart Financial Report 16th of May 2024 | PairCorr |
0.88 | AMZN | Amazon Inc Aggressive Push | PairCorr |
0.84 | ACN | Accenture Plc Earnings Call This Week | PairCorr |
0.64 | VLKPF | Volkswagen AG VZO | PairCorr |
Moving against Albireo Stock
0.86 | MMM | 3M Company Sell-off Trend | PairCorr |
0.78 | INTC | Intel Fiscal Quarter End 31st of March 2024 | PairCorr |
0.76 | BA | Boeing Fiscal Quarter End 31st of March 2024 | PairCorr |
0.44 | PFE | Pfizer Inc Fiscal Quarter End 31st of March 2024 | PairCorr |
The ability to find closely correlated positions to Albireo Pharma could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Albireo Pharma when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Albireo Pharma - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Albireo Pharma to buy it.
The correlation of Albireo Pharma is a statistical measure of how it moves in relation to other equities. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Albireo Pharma moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Albireo Pharma moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Albireo Pharma can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any Company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of labor statistics. Note that the Albireo Pharma information on this page should be used as a complementary analysis to other Albireo Pharma's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.
Other Consideration for investing in Albireo Stock
If you are still planning to invest in Albireo Pharma check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Albireo Pharma's history and understand the potential risks before investing.
Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
Fundamental Analysis View fundamental data based on most recent published financial statements | |
Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
Content Syndication Quickly integrate customizable finance content to your own investment portal | |
Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account |